Shandong Wohua Pharmaceutical Co., Ltd.

XSEC:002107 Stock Report

Market Cap: CN¥2.9b

Shandong Wohua Pharmaceutical Past Earnings Performance

Past criteria checks 1/6

Shandong Wohua Pharmaceutical's earnings have been declining at an average annual rate of -18%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 0.9% per year. Shandong Wohua Pharmaceutical's return on equity is 2.9%, and it has net margins of 3.2%.

Key information

-18.0%

Earnings growth rate

-18.2%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate-0.9%
Return on equity2.9%
Net Margin3.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shandong Wohua Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:002107 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247702447638
30 Jun 248123350937
31 Mar 248904357038
31 Dec 239105956745
30 Sep 239788659748
30 Jun 231,0048961153
31 Mar 2399110657752
01 Jan 231,01510759050
30 Sep 2298410655546
30 Jun 2293111850544
31 Mar 2295013949549
01 Jan 2294316347247
30 Sep 2196717549256
30 Jun 211,03719051554
31 Mar 211,04118652649
31 Dec 201,00617951047
30 Sep 2096918547343
30 Jun 2092615548144
31 Mar 2089112647453
31 Dec 198609648452
30 Sep 198575153156
30 Jun 198343953156
31 Mar 197774249747
31 Dec 187744649240
30 Sep 187714248831
30 Jun 187595944529
31 Mar 187545544519
31 Dec 177275742316
30 Sep 17653673729
30 Jun 17612593580
31 Mar 17589523530
31 Dec 16563493360
30 Sep 16552533220
30 Jun 16516562980
31 Mar 16486662630
31 Dec 15469712470
30 Sep 15463872360
30 Jun 15461792400
31 Mar 15481622610
31 Dec 14438432500
30 Sep 14384222320
30 Jun 14338132240
31 Mar 14266111900
31 Dec 13256111870

Quality Earnings: 002107 has high quality earnings.

Growing Profit Margin: 002107's current net profit margins (3.2%) are lower than last year (8.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 002107's earnings have declined by 18% per year over the past 5 years.

Accelerating Growth: 002107's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002107 had negative earnings growth (-71.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-2.5%).

Return on Equity

High ROE: 002107's Return on Equity (2.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 17:50
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Wohua Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution